Corrado Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-33
Closed -$1.47K 165
2022
Q4
$1.47K Buy
+33
New +$1.47K ﹤0.01% 347